Literature DB >> 20740570

Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.

Peter P Urban1, Ingmar Wellach, Siegbert Faiss, Peter Layer, Thorsten Rosenkranz, Karl Knop, Joachim Weis.   

Abstract

We describe two patients who developed subacute axonal peripheral neuropathy under duodopa treatment. Comprehensive diagnostic workup including muscle and sural nerve biopsy revealed that the most probable cause of subacute axonal peripheral neuropathy was cobalamin and vitamin B6 deficiency in both the patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740570     DOI: 10.1002/mds.23342

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

Review 1.  Advances in the laboratory evaluation of peripheral neuropathies.

Authors:  Mengjing Chloe Huan; Mark Bromberg
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

2.  PINK1: pumps, paraesthesia, punding and psychosis.

Authors:  Dominic C Paviour; Marie-Helene Marion
Journal:  J Neurol       Date:  2011-11-30       Impact factor: 4.849

Review 3.  Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert.

Authors:  Diego Santos-García; Raúl de la Fuente-Fernández; Francesc Valldeoriola; Antonio Palasí; Fátima Carrillo; Mónica Grande; Pablo Mir; Oriol De Fabregues; Jordi Casanova
Journal:  J Neurol       Date:  2012-01-24       Impact factor: 4.849

Review 4.  Therapy for Parkinson's disease: what is in the pipeline?

Authors:  Fabrizio Stocchi
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 5.  Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

Authors:  Johan Virhammar; Dag Nyholm
Journal:  Ther Adv Neurol Disord       Date:  2016-12-01       Impact factor: 6.570

Review 6.  Novel Levodopa Formulations for Parkinson's Disease.

Authors:  Maria Eliza Freitas; Marta Ruiz-Lopez; Susan H Fox
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

7.  Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation.

Authors:  Sophie M Lehnerer; Urban M Fietzek; Michael Messner; Andres O Ceballos-Baumann
Journal:  J Neural Transm (Vienna)       Date:  2014-04-08       Impact factor: 3.575

8.  Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.

Authors:  Carsten Buhmann; R Hilker; P Lingor; C Schrader; J Schwarz; M Wolz; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-22       Impact factor: 3.575

9.  Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease.

Authors:  Jin-Sung Park; Donghwi Park; Pan-Woo Ko; Kyunghun Kang; Ho-Won Lee
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

Review 10.  Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.

Authors:  Giovanni Abbruzzese; Paolo Barone; Ubaldo Bonuccelli; Leonardo Lopiano; Angelo Antonini
Journal:  Funct Neurol       Date:  2012 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.